Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study

SUMMARY: Bisphosphonate treatment is used to prevent bone fractures. A controversial association of bisphosphonate use and risk of atrial fibrillation has been reported. In our study, current alendronate users were associated with a higher risk of atrial fibrillation as compared with those who had s...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera, L., Leal, I., Lapi, F., Schuemie, M., Arcoraci, V., Cipriani, F., Sessa, E., Vaccheri, A., Piccinni, C., Staniscia, T., Vestri, A., Di Bari, M., Corrao, G., Zambon, A., Gregori, D., Carle, F., Sturkenboom, M., Mazzaglia, G., Trifiro, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428862/
https://www.ncbi.nlm.nih.gov/pubmed/25752621
http://dx.doi.org/10.1007/s00198-014-3020-y

Ejemplares similares

Ejemplares similares